PureTech Health
Adam Good has a diverse work experience in the pharmaceutical and biotech industry. Adam is currently serving as the Senior Director of Program Management and Operations at PureTech Health since January 2022. Prior to this, they worked as the Vice President of Product Development at NeuBase Therapeutics, Inc. from November 2019 to December 2021. Adam also held the position of Senior Director of Project Management at ConnectiveRx from September 2017 to November 2019. Adam has a background in program management, strategic development planning, and team collaboration. Earlier in their career, Adam served as the Director of Program Management at Symic Bio and held multiple roles at Hyperion Therapeutics and Bayer Pharmaceuticals. Overall, Adam has extensive experience in managing and driving the development of new products in the pharmaceutical industry.
Adam Good has an MS degree in Chemistry from the University of San Francisco and a BS (ACS Certified) degree in Chemistry with a minor in Math from Wittenberg University. Adam also holds a certification as a Project Management Professional (PMP) from the Project Management Institute.
This person is not in any offices
PureTech Health
4 followers
PureTech (Nasdaq: PRTC, LSE: PRTC) is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.